Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
18 April 2017 |
Main ID: |
ChiCTR-OPC-15006122 |
Date of registration:
|
2015-03-16 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
The Effect of Ultrasound-guided Ropivacaine Combined with Dexmedetomidine in Fascia Iliaca Compartment Block for Postoperative Analgesia After Lower Limb Fracture Operation
|
Scientific title:
|
The Effect of Ultrasound-guided Ropivacaine Combined with Dexmedetomidine in Fascia Iliaca Compartment Block for Postoperative Analgesia After Lower Limb Fracture Operation |
Date of first enrolment:
|
2015-04-01 |
Target sample size:
|
Group R:25;Group RD :25; |
Recruitment status: |
Pending |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=10611 |
Study type:
|
Observational study |
Study design:
|
Cross-sectional
|
Phase:
|
I (Phase I study)
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Zhang Qian
|
Address:
|
57 Zhonghua West Road, Lianyun District, Lianyungang, Jiangsu
|
Telephone:
|
+86 15262005637 |
Email:
|
15262005637@163.com |
Affiliation:
|
Lianyungang Oriental Hospital |
|
Name:
|
Cheng Fang
|
Address:
|
57 Zhonghua West Road, Lianyun District, Lianyungang, Jiangsu
|
Telephone:
|
+86 13851260712 |
Email:
|
chengfang-1991@163.com |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Patients with Lower Limb Fracture, ASA I-II grade,BMI 18~24 kg/m2.
Exclusion criteria: Patients can not cooperate and exchange;Severe liver, kidney and blood system dysfunction; Formulation ingredients used in this study for patients with a history of allergy; Block failure patients.
Age minimum:
18
Age maximum:
60
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Lower Limb Fracture
|
Intervention(s)
|
Group R:Use ropivacaine;Group RD :use dexmedetomidine and ropivacaine;
|
Primary Outcome(s)
|
VAS;OAA/S;CRP;
|
Source(s) of Monetary Support
|
Municipal Health Bureau, Commitment unit
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|